Your browser doesn't support javascript.
loading
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.
Hohmann, Miriam S; Habiel, David M; Espindola, Milena S; Huang, Guanling; Jones, Isabelle; Narayanan, Rohan; Coelho, Ana Lucia; Oldham, Justin M; Noth, Imre; Ma, Shwu-Fan; Kurkciyan, Adrianne; McQualter, Jonathan L; Carraro, Gianni; Stripp, Barry; Chen, Peter; Jiang, Dianhua; Noble, Paul W; Parks, William; Woronicz, John; Yarranton, Geoffrey; Murray, Lynne A; Hogaboam, Cory M.
Afiliação
  • Hohmann MS; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Habiel DM; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Espindola MS; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Huang G; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Jones I; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Narayanan R; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Coelho AL; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Oldham JM; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California, Davis, Sacramento, California, USA.
  • Noth I; Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Ma SF; Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • Kurkciyan A; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • McQualter JL; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Carraro G; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Stripp B; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Chen P; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Jiang D; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Noble PW; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Parks W; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Woronicz J; KaloBios Pharmaceuticals, Inc. (now Humanigen, Inc.), Burlingame, California, USA.
  • Yarranton G; KaloBios Pharmaceuticals, Inc. (now Humanigen, Inc.), Burlingame, California, USA.
  • Murray LA; MiroBio Ltd, Oxford, United Kingdom.
  • Hogaboam CM; Women's Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
JCI Insight ; 6(11)2021 06 08.
Article em En | MEDLINE | ID: mdl-33945505
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor EphA3 / Receptores CCR10 / Fibrose Pulmonar Idiopática / Células-Tronco Mesenquimais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor EphA3 / Receptores CCR10 / Fibrose Pulmonar Idiopática / Células-Tronco Mesenquimais Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article